Sarah London is CEO of Centene Corporation, a Fortune 50 company and leading national healthcare payer that takes a unique local approach to providing fully integrated, high-quality, and cost-effective services. Centene focuses on government-sponsored healthcare programs and primarily serves under-insured and uninsured individuals.
Ms. London has spent her career at the intersection of health data, technology and healthcare delivery transformation. Before her 2022 appointment to CEO, she was Centene’s Vice Chairman, responsible for strategy, technology, ancillary services, enterprise compliance and quality, as well as for Centene’s portfolio of independent, non health plan companies. Prior to Centene she was an Operating Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Previously, she held roles at Optum Analytics, first serving as Vice President of Client Services and then later becoming its Chief Product Officer, where she drove the strategy and commercialization of the company’s integrated data solutions for the provider, payer, and life sciences markets. She joined Optum after it acquired Humedica, a clinical analytics start-up, where she led the client services and operations team.
Ms. London’s career has been driven by her early experiences working to improve health care for people of all backgrounds, holding positions at Accretive Health (now R1 RCM), which works with health systems and providers on their revenue cycle to create greater financial stability and better patient experiences, and at Health Leads, a leading national organization that systemically addresses social determinants of health through data and unique community partnership models.
Ms. London graduated magna cum laude from Harvard College where she played Division I tennis. She also holds a Master of Business Administration with High Honors from the University of Chicago Booth School of Business.
What is Sarah London's net worth?
The estimated net worth of Sarah London is at least $22.84 million as of March 17th, 2023. Ms. London owns 313,953 shares of Centene stock worth more than $22,836,941 as of April 26th. This net worth evaluation does not reflect any other assets that Ms. London may own. Additionally, Ms. London receives an annual salary of $4,980,000.00 as CEO at Centene. Learn More about Sarah London's net worth.
What is Sarah London's salary?
How do I contact Sarah London?
Has Sarah London been buying or selling shares of Centene?
Sarah London has not been actively trading shares of Centene over the course of the past ninety days. Most recently, on Friday, March 17th, Sarah London bought 30,000 shares of Centene stock. The stock was acquired at an average cost of $62.60 per share, with a total value of $1,878,000.00. Following the completion of the transaction, the chief executive officer now directly owns 313,953 shares of the company's stock, valued at $19,653,457.80. Learn More on Sarah London's trading history.
Who are Centene's active insiders?
Centene's insider roster includes Andrew Asher (Exec. VP & CFO ), Andrew Asher (CFO), Orlando Ayala (Director), Shannon Bagley (EVP), Mark Brooks (EVP), Kenneth Burdick (EVP), Brandy Burkhalter (COO), Katie Casso (SVP), Robert Ditmore (Director), Kenneth Fasola (President), Richard Gephardt (Director), Jesse Hunter (NASDAQ), Christopher Koster (SVP), Brent Layton (EVP), Sarah London (CEO), Michael Neidorff (CEO), John Roberts (Director), Lori Robinson (Director), Theodore Samuels, II (Director), Jeffrey Schwaneke (CFO), David Thomas (EVP), Tommy Thompson (Director), and Colin Toney (EVP). Learn More on Centene's active insiders.
Are insiders buying or selling shares of Centene?
In the last twelve months, insiders at the sold shares 3 times. They sold a total of 23,400 shares worth more than $1,768,166.00. The most recent insider tranaction occured on February, 13th when Director Lori Jean Robinson sold 10,000 shares worth more than $774,100.00. Insiders at Centene own 0.3% of the company.
Learn More about insider trades at Centene. Information on this page was last updated on 2/13/2024.
